-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 O7IJa4jAE6qP9rlbX30Dp2mVWbwRollDJ8ezjzKzsH4Jkg80mGOQDLclDr/fZlhc
 VW7ujdqlJi3nW2oPeMZtoQ==

<SEC-DOCUMENT>0001396093-07-000020.txt : 20070817
<SEC-HEADER>0001396093-07-000020.hdr.sgml : 20070817
<ACCEPTANCE-DATETIME>20070817161919
ACCESSION NUMBER:		0001396093-07-000020
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070815
FILED AS OF DATE:		20070817
DATE AS OF CHANGE:		20070817

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NABI  BIOPHARMACEUTICALS
		CENTRAL INDEX KEY:			0000072444
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				591212264
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1225

	BUSINESS ADDRESS:	
		STREET 1:		5800 PARK OF COMMERCE BLVD N W
		STREET 2:		STE 322
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487
		BUSINESS PHONE:		5619895800

	MAIL ADDRESS:	
		STREET 1:		5800 PARK OF COMMERCE BLVD NW
		STREET 2:		STE 322
		CITY:			BOCA RATON
		STATE:			FL
		ZIP:			33487

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NABI /DE/
		DATE OF NAME CHANGE:	19960405

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NORTH AMERICAN BIOLOGICALS INC
		DATE OF NAME CHANGE:	19920703

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Hudson Leslie
		CENTRAL INDEX KEY:			0001321265

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-04829
		FILM NUMBER:		071065422

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		215-746-4771

	MAIL ADDRESS:	
		STREET 1:		509 S. 24TH STREET
		CITY:			PHILADELPHIA
		STATE:			PA
		ZIP:			19146
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2007-08-15</periodOfReport>

    <issuer>
        <issuerCik>0000072444</issuerCik>
        <issuerName>NABI  BIOPHARMACEUTICALS</issuerName>
        <issuerTradingSymbol>NABI</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001321265</rptOwnerCik>
            <rptOwnerName>Hudson Leslie</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O NABI BIOPHARMACEUTICALS</rptOwnerStreet1>
            <rptOwnerStreet2>5800 PARK OF COMMERCE BLVD., N.W.</rptOwnerStreet2>
            <rptOwnerCity>BOCA RATON</rptOwnerCity>
            <rptOwnerState>FL</rptOwnerState>
            <rptOwnerZipCode>33487</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Interim President &amp; CEO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2007-08-15</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>D</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>1307</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>11759</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value></value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">11,759 of the 13,066 shares of restricted stock originally awarded on February 15, 2007 vested in acordance with the terms of the award.  The 1,307 shares reported as disposed did not vest and have been forfeited to Nabi Biopharmaceuticals in accordance with the terms of the award.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ James E. Dawson, as attorney-in-fact</signatureName>
        <signatureDate>2007-08-16</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----